TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Enorama Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
1,358
|
6,847
|
11,036 |
| Financial expenses |
3,589
|
2,088
|
802 |
| Earnings before taxes |
-44,613
|
-42,030
|
-27,742 |
| EBITDA |
-38,579
|
-37,933
|
-25,559 |
| Total assets |
34,385
|
48,721
|
50,933 |
| Current assets |
12,964
|
11,752
|
22,409 |
| Current liabilities |
10,218
|
12,426
|
11,678 |
| Equity capital |
19,538
|
31,524
|
21,354 |
| - share capital |
6,394
|
1,461
|
1,201 |
| Employees (average) |
5
|
9
|
10 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
56.8%
|
64.7%
|
41.9% |
| Turnover per employee |
272
|
761
|
1,104 |
| Profit as a percentage of turnover |
-3285.2%
|
-613.8%
|
-251.4% |
| Return on assets (ROA) |
-119.3%
|
-82.0%
|
-52.9% |
| Current ratio |
126.9%
|
94.6%
|
191.9% |
| Return on equity (ROE) |
-228.3%
|
-133.3%
|
-129.9% |
| Change turnover |
-5,489
|
-4,189
|
8,890 |
| Change turnover % |
-80%
|
-38% | |
| Chg. No. of employees |
-4
|
-1
|
3 |
| Chg. No. of employees % |
-44%
|
-10% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.